SFX by Ex Libris Inc.

Title:	Cancer bypasses the lymph nodes
Source:	Science [0036-8075] Markowitz, S D yr:2017

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ferrarelli, Leslie K. "Treating WNT-driven colorectal cancer." Science 356.6345 (2017): 1346-1348.
description	2.	Kamphorst, Alice O. "Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent." Science 355.6332 (2017): 1423-1427.
description	3.	Hui, E. "T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition." Science 355.6332 (2017): 1428-1433.
description	4.	Ballabio, A. "Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth." Science 356.6343 (2017): 1188-1192.
description	5.	Sivan, A. "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy." Science 350.6264 (2015): 1084-9.
description	6.	Licht, Jonathan D. "DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension." Cell 162.5 (2015): 938-9.
description	7.	Guislain, A. "Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma." Cancer immunology and immunotherapy 64.10 (2015): 1241-50.
description	8.	Leach, D R R. "Enhancement of antitumor immunity by CTLA-4 blockade." Science 271.5256: 1734-1736.
description	9.	Vétizou, M. "Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota." Science 350.6264 (2015): 1079-84.
description	10.	Snyder, A. "IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?" Science 350.6264 (2015): 1031-2.
description	11.	Iida, N. "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment." Science 342.6161 (2013): 967-970.
description	12.	Mathieu, M. "Notch signaling regulates PD-1 expression during CD8 + T-cell activation." Immunology and cell biology 91.1 (2012): 82-8.
description	13.	Topalian, Suzanne L. "Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity." Current opinion in immunology 24.2 (2012): 207-212.
description	14.	Mellman, I. "Cancer immunotherapy comes of age." Nature 480.7378 (2011): 480-489.
description	15.	Mo, M. "Reoperative pulmonary thromboendarterectomy." The annals of thoracic surgery (1999): 1770-6.
description	16.	Kwon, E D D. "Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer." Proceedings of the National Academy of Sciences of the United States of America 94.15 (1997): 8099-103.
description	17.	Hodi, Steven S. "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma." New England Journal of Medicine, The 363.8 (2010): 711-723.
description	18.	Zou, W. "Inhibitory B7-family molecules in the tumour microenvironment." Nature reviews. Immunology 8.6 (2008): 467-77.
description	19.	Gladue, R P P. "The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma." Cancer immunology, immunotherapy 50.3 (2001): 125-33.
description	20.	Honjo, T. "Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death." The EMBO journal 11.11 (1992): 3887-95.